2024
|
Invention
|
Therapeutic agent for polycythemia. The present invention addresses the problem of defining an ap... |
|
Invention
|
225ac-labeled anti-cdh3 antibodies. The present invention addresses the problem of providing radi... |
|
Invention
|
Composition containing buffer.
Provided is a composition containing a buffer to be used at the t... |
2023
|
Invention
|
Therapeutic agent for nk cell tumor. The present invention addresses the problem of providing a t... |
2022
|
Invention
|
Ros (reactive oxygen species) production enhancing agent.
It is an object of the present inventi... |
|
Invention
|
Reactive oxygen species (ros) production promoter. The present invention addresses the problem of... |
2021
|
Invention
|
Method for determining medicinal effect or sensitivity of anti-transferrin receptor antibody.
It... |
|
Invention
|
Method for determining sensitivity or medicinal effect of anti-transferrin receptor antibody. The... |
2020
|
Invention
|
Therapeutic drug for carcinomatous peritonitis.
It is an object of the present invention to prov... |
|
Invention
|
Therapeutic agent for carcinomatous peritonitis. The present invention addresses the problem of p... |
|
Invention
|
Therapeutic drug for polycythemia.
It is an object of the present invention to provide a therape... |
|
Invention
|
Therapeutic agent for polycythemia. The present invention addresses the problem of providing a th... |
2019
|
Invention
|
Agent for inhibiting iron uptake into cells.
It is an object of the present invention to provide... |
|
Invention
|
Inhibitor of cellular iron uptake. The present invention addresses the problem of providing an in... |
|
Invention
|
Agent for inhibiting iron uptake into cells. The present invention addresses the problem of provi... |
2017
|
Invention
|
Composition containing buffer. 177Lu. At least one kind of buffer selected from the group consist... |
2016
|
Invention
|
Antibody capable of specifically binding to cd147 molecule, and use thereof. Provided are a monoc... |
2014
|
Invention
|
Method for diagnosing cancer by detecting gpc3. Provided is a method for diagnosing cancer by det... |
|
Invention
|
Cancer diagnosis and treatment of cancer using anti-robo1 antibody. A method for diagnosing cance... |
|
Invention
|
Anti-podoplanin antibody. The objective of the present invention is to provide a variety of anti... |
|
Invention
|
Antibody which specifically reacts with human integrin a6b4. It is an object of the present inven... |
|
Invention
|
Antibody which specifically reacts with human integrin a6b4. The purpose of the present invention... |
|
Invention
|
Anti-influenza virus neutralizing antibody.
It is an object of the present invention to provide ... |
|
Invention
|
Anti-influenza virus-neutralizing antibody. The purpose of the present invention is to provide a... |
|
Invention
|
Radioactive metal-labeled anti-cadherin antibody.
A radioactive metal-labeled anti-cadherin anti... |
|
Invention
|
Method of classifying antibody, method of identifying antigen, method of obtaining antibody or an... |
|
Invention
|
Anti-cdh3 humanized antibody, drug conjugate thereof, and use thereof. The present invention prov... |
|
Invention
|
Anti-cdh3 humanized antibody, drug conjugate thereof, and use thereof. The present invention addr... |
|
Invention
|
Anti-cdh3 humanized antibody, drug conjugate thereof, and utilization of same. The present invent... |
2013
|
Invention
|
Antibody capable of specifically recognizing transferrin receptor. The present invention provides... |
|
Invention
|
Anti-human cd40 monoclonal antibody, and use thereof. Provided is a monoclonal antibody exhibitin... |
|
Invention
|
Anti-human cd40 monoclonal antibody, and use thereof. Provided is a monoclonal antibody which exh... |
|
Invention
|
Agent for treating or preventing systemic inflammatory response syndrome. The present invention p... |
|
Invention
|
Antibody for detecting dna damage in cells utilizing cell membrane surface antigen ly6d. To provi... |
|
Invention
|
Highly effective anti-cadherin antibody for induction of antibody-dependent cellular cytotoxicity... |
2012
|
Invention
|
Image-based tumor diagnosis agent containing anti-human transferrin receptor antibody. The presen... |
|
Invention
|
Anti-human p-cadherin (cdh3) recombinant antibody. It is an object to provide a recombinant antib... |
|
Invention
|
Anti-human p-cadherin (cdh3) recombinant antibody. The problem addressed is to provide an anti-CD... |
|
Invention
|
Antibody capable of specifically recognizing transferrin receptor. An object of present invention... |
|
Invention
|
Antibody capable of specifically recognizing transferrin receptor. The purpose of the present inv... |
|
Invention
|
Antibody specifically recognising transferrin receptor. The purpose of the present invention is ... |
|
Invention
|
Drug conjugate comprising anti-cdh3 (p-cadherin) antibody. It is an object of the present inventi... |
|
Invention
|
Conjugate of anti-cdh3 (p-cadherin) antibody and drug. The purpose of the present invention is to... |
|
Invention
|
Drug conjugate comprising anti-cdh3 (pcadherin) antibody. The purpose of the present invention is... |
2011
|
Invention
|
Anti-cdh3 antibody having high internalization capacity. It is an object of the present invention... |
|
Invention
|
Therapeutic agents for alzheimer's disease and cancer. To provide a therapeutic drug for Alzheime... |